Gelteq Limited Ordinary Shares (GELS) vs Lexaria Bioscience Corp. (LEXX)
A side-by-side comparison of Gelteq Limited Ordinary Shares and Lexaria Bioscience Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GELS
Gelteq Limited Ordinary Shares
$0.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LEXX
Lexaria Bioscience Corp.
$3.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GELS vs LEXX
growth of $100 · dividends reinvested · last 2yGELS -81.5% (-57.0%/yr)LEXX -92.7% (-72.9%/yr)GELS compounded faster over this window
GELS LEXX
GELS vs LEXX: by the numbers
- •LEXX is the larger company ($5M vs $5M market cap).
- •Both run net losses; LEXX's is the smaller (-3985.58% vs -4011.86% net margin).
Metrics side by side
Valuation
| Metric | GELS | LEXX |
|---|---|---|
| P/S ratio | N/A | 27.60 |
| P/B ratio | 0.56 | 1.13 |
Profitability
| Metric | GELS | LEXX |
|---|---|---|
| Gross margin | 100.00% | 100.00% |
| Operating margin | -3317.65% | -1683.01% |
| Net margin | -4011.86% | -3985.58% |
| ROE | -42.05% | -163.18% |
| ROIC | -27.41% | -175.26% |
Growth (annualized)
| Metric | GELS | LEXX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.92% |
| Total return CAGR (5Y) | N/A | -50.86% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.